KOD - Kodiak Sciences Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

141.8M

Cash

421.2M

Avg Qtr Burn

-52.63M

Short % of Float

5.39%

Insider Ownership

5.70%

Institutional Own.

80.45%

Qtr Updated

03/31/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
KSI-301 (GLOW) Details Non-proliferative diabetic retinopathy Big Mover™ Suspected Mover™ Susp. Mover™	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KSI-301 (anti-VEGF) Details Diabetic macular edema Big Mover™ Suspected Mover™ Susp. Mover™	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KSI-301 (BEACON) Details Retinal vein occlusion	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KSI-301 (DAZZLE) Details Wet age-related macular degeneration Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KSI-501 (anti-VEGF) Details Diabetic macular edema, Eye disease	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.